Fatigue in Sjögren's syndrome: Relationship with fibromyalgia, clinical and biological features

Clinical and Experimental Rheumatology

Volumn 28, Issue 6 SUPPL. 63, 2010, Pages

  Priori, R ^a   Iannuccelli, C ^a   Alessandri, C ^a   Modesti, M ^a   Antonazzo, B ^a   Di Lollo, A C ^a   Valesini, G ^a   Di Franco, M ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Cytokines; Disease activity; Fatigue; Fibromyalgia; Sj gren's syndrome

Indexed keywords

CYTOKINE;

ADULT; AGED; ANXIETY; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE SEVERITY; FATIGUE; FEMALE; FIBROMYALGIA; HUMAN; MOOD DISORDER; PAIN ASSESSMENT; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SCORING SYSTEM; SJOEGREN SYNDROME; BLOOD; DEPRESSION; EVALUATION; IMMUNOLOGY; ITALY; MIDDLE AGED; PAIN; PATHOPHYSIOLOGY;

ADULT; AGED; ANXIETY; CYTOKINES; DEPRESSION; FATIGUE; FEMALE; FIBROMYALGIA; HUMANS; ITALY; MIDDLE AGED; PAIN; SJOGREN'S SYNDROME;

EID: 79952664516     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. .FOX R: Sjögren's syndrome. Lancet 2005; 366:321-31.
2. BINARD A, DEVAUCHELLE-PENSEC V, FAUTREL B, JOUSSE S, YOUINOU P, SARAUX A: Epidemiology of Sjögren's syndrome: where are we now? Clin Exp Rheumatol 2007; 25: 1-4.
3. RAMOS-CASALS M, SOLANS R, ROSAS J et al.: GEMESS Study Group: Primary Sjögren syndrome in Spain: clinical and immunologic expression in 1010 patients. Medicine 2008;87:210-9.
4. VITALI C, BOMBARDIERI S, JONSSON R et al.: European Study Group on Classification Criteria for Sjögren's Syndrome: Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group Ann Rheum Dis 2002; 6: 554-8.
5. BARENDREGT PJ, VISSER M,SMETS E et al.: Fatigue in primary Sjögren's syndrome. Ann Rheum Dis 1998; 57: 291-5.
6. MARKUSSE HM, OUDKERK M, VROOM TM, BREEDVELD FC: Primary Sjögren's syndrome: clinical spectrum and mode of presentation based on an analysis of 50 patients selected from a department of rheumatology. Neth J Med 1992; 40: 125-34.
7. SEGAL B,THOMAS W, ROGERS T et al:. Prevalence, severity, and predictors of fatigue in subjects with primary Sjögren's syndrome Arthritis Rheum 2008; 59: 1780-7.
8. OSTUNI P, BOTSIOS C, SFRISO P et al.: Fibromyalgia in Italian patients with primary Sjögren's syndrome. Joint Bone Spine 2002; 69: 51-7.
9. GILES I, ISENBERG D: Fatigue in primary Sjögren's syndrome: is there a link with the fibromyalgia syndrome? Ann Rheum Dis 2000; 59: 875-8.
10. TISHLER M, BARAK Y, PARAN D, YARON M: Sleep disturbances, fibromyalgia and primary Sjögren's syndrome. Clin Exp Rheumatol 1997;15:71-4.
11. LlNDVALL B, BENGTSSON A, ERNERUDH J, ERIKSSON P: Subclinical myositis is common in primary Sjögren's syndrome and is not related to muscle pain. J Rheumatol 2002;29:717-25.
12. STROMECK B, EKDAHL C, MANTHORPE R, JACOBSSON LT: Physical capacity in women with primary Sjögren's syndrome: A Controlled Study. Arthritis Rheum 2003; 49: 681-8.
13. MANDL T, HAMMAR O, THEANDER E, WOLLMER P, OHLSSON B: Autonomic nervous dysfunction development in patients with primary Sjögren's syndrome: a followup study. Rheumatology 2010; 49: 1101-06.
14. TENSING EK, SOLOVIEVA SA.TERVAHARTIALA T et al:. Fatigue and health profile in sicca syndrome of Sjögren's and non-Sjögren's syndrome origin. Clin Exp Rheumatol 2001; 19:313-6.
15. HANSEN B, MANTHORPE R: Antibodies against SS-B/La and SS-A/Ro antigens in patients with primary Sjögren's syndrome. Scand J Rheumatol 1986; 61: 93-7.
16. BAX HI, VRIESENDORP TM, KALLENBERG CG, KALK WW: Fatigue and immune activity in Sjögren's syndrome. Ann Rheum Dis 2002; 61: 284.
17. VÍTALI C, PALOMBI G, BALDINI C et al.: Sjögren's Syndrome Disease Damage Index and Disease Activity Index: scoring systems for the assessment of disease damage and disease activity in Sjögren's syndrome, derived from an analysis of a cohort of Italian patients. Arthritis Rheum 2007; 56: 2223-31
18. SEROR R, RAVAUD P, BOWMAN S et al.: EULAR Sjögren's Syndrome Disease Activity Index (ESSDAI): Development of a consensus systemic disease activity index in primary Sjögren's syndrome. Ann Rheum Dis 2009 69; 1103-9.
19. SARZI-PUTTINI, ATZENI F, FIORINI T et al.: Validation of an Italian version of the Fibromyalgia Impact Questionnaire (FIQ-I). Clin Exp Rheumatol 2003; 21: 459-64.
20. SALAFFI F, SARZI-PUTTINI P, CIAPETTI A, ATZENI F: Assessment instruments for patients with fibromyalgia: properties, applications and interpretation. Clin Exp Rheumatol 2009; 27 (Suppl. 56): S92-105.
21. ZUNG WW: A self-rating depression scale. Arch Gen Psychiatry 1965; 12: 63-70
22. ZUNG WW: A rating instrument for anxiety disorders. Psychosomatics 1971; 12: 371-9
23. WOLFE F, SMYTHE HA, YUNUS MB et al.: The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia: Report of the Multicenter Criteria Committee. Arthritis Rheum 1990; 33: 160-72.
24. LOGE JH, EKEBERG O, KAASA S: Fatigue in the general Norwegian population: normative data and associations. J Psychosom Res 1998;45:53-65.
25. CHEN MK: The epidemiology of self-perceived fatigue among adults. Prev Med 1986; 15:74-81.
26. WOLFE F, HAWLEY DJ, WILSON K: The prevalence and meaning of fatigue in rheumatic disease. J Rheumatol 1996; 23: 1407-17.
27. HEWLETT S, COCKSHOT Z, BYRON M et al: Patients' perceptions of fatigue in rheumatoid arthritis: overwhelming, uncontrollable, ignored. Arthritis Rheum 2005; 53: 697-702.
28. OMDAL R, WATERLOO K, KOLDINGSNES W, HUSBY G, MELLGREN SI: Fatigue in patients with systemic lupus erythematosus: the psych. J Rheumatol 2003; 30: 283-7.
29. D'ELlA HF, REHNBERG E, KVIST G, ERICSSON A, KONTTINEN Y, MANNERKORPI K: Fatigue and blood pressure in primary Sjogren's syndrome. Scand J Rheumatol 2008; 37: 284-92.
30. WHITEHEAD L: The Measurement of Fatigue in Chronic Illness: A Systematic Review of Unidimensional and Multidimensional Fatigue Measures. J Pain Symptom Management 2009,37: 107-28.
31. DITTNER AJ, WESSELY SC, BROWN RG: The assessment of fatigue: a practical guide for clinicians and researchers. J Psychosom Res 2004; 56: 157-70.
32. NG WF, BOWMAN SJ: Primary Sjögren's syndrome: too dry and too tired. Rheumatology 2010; 49: 844-53.
33. BOWMAN SJ, BOOTH DA, PLATTS RG: Measurement of fatigue and discomfort in primary Sjögren's syndrome using a new questionnaire tool. Rheumatology 2004; 43: 758-64.
34. GODAERT GL, HARTKAMP A, GEENEN R et al:. Fatigue in daily life in patients with primary Sjögren's syndrome and systemic lupus erythematosus. Ann NY Acad Sci 2002; 966: 320-6.
35. JACOBSSON L, KIRTAVA Z, OLSSON G, AXELL T, MANTHORPE R: Tiredness in patients with primary Sjögren's syndrome. Clin Rheumatol 1995; 14 (Suppl. 1): 51-5.
36. DANTZER R: Cytokine-induced sickness behaviour: where do we stand? Brain Behav ImmunimV, 15:7-24.
37. Schiller JH, Storer BE, Witt PL et al.: Biological and clinical effects of intravenous tumor necrosis factor-alpha administered three times weekly. Cancer Res 1991; 51: 1651-8.
38. FARAG SS, GEORGE SL, LEE EJ et al:. Postremission therapy with low-dose interleukin 2 with or without intermediate pulse dose interleukin 2 therapy is well tolerated in elderly patients with acute myeloid leukemia: Cancer and Leukemia Group B study 9420. Clin Cancer Res 2002; 8: 2812-19.
39. SPATH-SCHWALBE E, HANSEN K, SCHMIDT F et al:. Acute effects of recombinant human interleukin-6 on endocrine and central nervous sleep functions in healthy men. J Clin EndocrinolMetab 1998; 83: 1573-9.
40. MATHIAS SD, COLWELL HH, MILLER DP, MORELAND LW, BUATTI M, WANKE L: Health-related quality-of-life and functional status of patients with rheumatoid arthritis randomly assigned to receive etanercept or placebo. Clin Ther 2000; 22: 128-39.
41. ROESCHER N, TAK PP, ILLEI GG: Cytokines in Sjögren's syndrome. Oral Dis 2009; 15: 519-26.
42. HARTKAMP A, GEENEN R, BIJL M, KRUIZE AA, GODAERT GL, DERKSEN RH: Serum cytokine levels related to multiple dimensions of fatigue in patients with primary Sjögren's syndrome. Ann Rheum Dis 2004; 63: 1335-37.
43. D'ELIA HF, BJURMAN C, REHNBERG E, KVIST G, KONTTINEN YT: Interleukin 6 and its soluble receptor in a central role at the neuroimmunoendocrine interface in Sjögren syndrome: an explanatory interventional study. Ann Rheum Dis 2009; 68: 285-6.
44. HARBOE E, TJENSVOLL AB, VEFRING HK, GØRANSSON LG, KVALØY JT, OMDAL R: Fatigue in primary Sjögren's syndrome - A link to sickness behaviour in animals? Brain Behav Immun 2009; 23: 1104-8.
45. DOHRENBUSCHR.GRÜTERICH M, GENTHE: Fibromyalgia and Sjögren syndrome - clinical and methodological aspects. Z Rheumatol 1996; 55: 19-27.
46. SALAFFI F, SARZI-PUTTINI P, GIROLIMETTI R, ATZENI F, GASPARINI S, GRASSI W: Health-related quality of life in fibromyalgia patients: a comparison with rheumatoid arthritis patients and the general population using the SF-36 health survey. Clin Exp Rheumatol 2009; 27 (Suppl. 56): S67-74.
47. MARTÍNEZ-LAVÍN M: Overlap of fibromyalgia with other medical conditions. Curr Pain Headache Rep 2001: 5: 347-50.
48. Dl FRANCO M, IANNUCCELLI C, VALESINI G: Neuroendocrine immunology of fibromyalgia. Ann N Y Acad Sci 2010; 1193: 84-90.
49. Dl FRANCO M, IANNUCCELLI C, ALESSANDRI C et al.: Autonomic dysfunction and neuropeptide Y in fibromyalgia. Clin Exp Rheumatol 2009; 27 (Suppl. 56): S75-8.
50. BRADLEY LA: Pathophysiology of fibromyalgia. Am J Med 2009; 122 (Suppl.): S22-30.
51. WALLACE DJ: Is there a role for cytokine based therapies in fibromyalgia. Curr Pharm Des 2006:12:17-22.
52. WALLACE DJ, MARGOLIN K, WALLER P: Fibromyalgia and interleukin-2 therapy for malignancy. Ann Intern Med 1988; 108: 909.
53. MCDONALD EM, MANN AH, THOMAS HC: Interferons as mediators of psychiatric morbidity. An investigation in a trial of recombinant alpha-interferon in hepatitis-B carriers. Lancet 1987; 2:1175-8.
54. BAX HI, VRIESENDORP TM, KALLENBERG CG, KALK WW: Fatigue and immune activity in Sjögren's syndrome. Ann Rheum Dis 2002; 61: 284.
55. HARBOE E, GREVE OJ, BEYER M et al.: Fatigue is associated with cerebral white matter hyperintensities in patients with systemic lupus erythematosus. J Neurol Neurosurg Psychiatry 2008; 79: 199-201.